New Zealand-Based Cancer Diagnostics Firm to Create 100 Jobs at PA Facility
01/30/2012
Pacific Edge is a cancer diagnostics company specializing in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer.
The firm's new 11,348-sq.-ft. space will serve as an office and processing facility for the analysis of its Cxbladder test, which uses the expression of genes in the patients' urine to detect the presence of bladder cancer accurately and non-invasively.
Planning and construction for the facility is currently underway. It will be located at the Hershey Center for Applied Research (HCAR), which is now building a "Knowledge Community" in partnership with Penn State University and the Penn State Milton S. Hershey Medical Center. This community offers tenants access to advanced technology and other research resources, and immerses them in a climate of innovation.
According to HCAR, Pacific Edge chose to bring its product to Hershey because of the Center's "direct engagement in nearly every aspect of the company's U.S. commercialization to date."
Most Read
-
-
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Q3 2019
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019
-
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
Q3 2020
-
A Heightened Focus on Reshoring
Q3 2020
-
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Q1 2020
-
How are Uncertain Times Altering Company Location Strategies?
Q3 2020